M. LA MACCHIA; A. GALUPPI; S. MEDORO; S. CAMMELLI; F. ROMANI; P. DE IACO; P. CASTELLUCCI; S. FANTI; M. COE; E. BARBIERI, The role of PETCT in the radiotherapy treatment planning of locally advanced cervical cancer, in: , «TUMORI», 2009, supplemento 8 n1, pp. S214 - S214 (atti di: XIX AIRO 2009, BOLOGNA, 14-17 NOVEMBRE 2009) [atti di convegno-abstract]
Bartalena T.; Rinaldi M.F.; Sverzellati N.; Allegri V.; Fanti S., Tract metastasis from previously unknown malignant pleural mesothelioma: a case report., «CASES JOURNAL», 2009, 2, pp. 7834 - 7834 [articolo]
Di Cicilia R.; Castellucci P.; Nannini M.; Balbi T.; Zannetti G.; Fanti S.; Biasco G.; Pantaleo M.A., Unusual finding of benign Abrikossoff tumor by F-18 FDG-PET mimicking melanoma recurrence., «CLINICAL NUCLEAR MEDICINE», 2009, 34(10), pp. 696 - 697 [articolo]
Maleddu, A.; Pantaleo, MARIA ABBONDANZA; Castellucci, Paolo; Astorino, M.; Nanni, Cristina; Nannini, Margherita; Busato, F.; Di Battista, M.; Farsad, M.; Lodi, F.; Fanti, Stefano; Biasco, Guido; Boschi, S., 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma., «TUMORI», 2009, 95(3), pp. 382 - 384 [articolo]
G.GHIGI; R.MICERA; A.M.MAFFIONE; P.CASTELLUCCI; S.CAMMELLI; I. AMMENDOLIA; C. NANNI; E. BARBIERI; G.GRASSETTO; S.FANTI; D.RUBELLO, 11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results, «IN VIVO», 2009, 23, pp. 105 - 110 [articolo]
Ambrosini V; Castellucci P; Rubello D; Nanni C; Musto A; Allegri V; Montini GC; Mattioli S; Grassetto G; Al-Nahhas A; Franchi R; Fanti S., 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid., «NUCLEAR MEDICINE COMMUNICATIONS», 2009, 30 (4), pp. 281 - 286 [articolo]
Ambrosini, V; Nanni, C; Zompatori, M; Castellucci, P; Allegri, V; Rubello, D; Montini, G; Grassetto, G; Lopci, E; Fantini, L; Franchi, R; Fanti, S, 68Ga-DOTA-NOC PET and CT retrospective analysis for neuroendocrine bone metastasis detection, in: European Journal of Nuclear Medicine and molecular Imaging. Abstracts Annual Congress of the EANM 2009, BERLIN, Springer, 2009, 36, suppl 2, pp. S202 - S202 (atti di: Annual Congress of the EANM, Barcelona, Spain, 9-14 Ottobre 2009) [atti di convegno-abstract]
Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M., A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients., «ANNALS OF ONCOLOGY», 2008, 19, pp. 769 - 773 [articolo]
Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M., A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma, «CANCER», 2008, 112(4), pp. 856 - 862 [articolo]
Rubello D.; Rampin L.; Banti E.; Grassetto G.; Massaro A.; Cittadin S.; Pavan L.; Cattelan A.M.; Fanti S.; Al-Nahhas A.; Gross M.D.; Alavi A., Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance of delayed 20-24-h imaging and semiquantitative analysis., «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29(11), pp. 994 - 998 [articolo]
Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S., Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET., «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29(8), pp. 705 - 710 [articolo]
A. Guido; P. Castellucci; F. Bunkheila; C. Fuccio; B. Rombi; C. Nanni; A. Cecconi; S. Fanti; E. Barbieri, Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer, in: , «NUCLEAR MEDICINE», 2008, 49 suppl 1, pp. 357P - 357P [atti di convegno-abstract]
Ambrosini V.; Tomassetti P.; Castellucci P.; Campana D.; Montini G.; Rubello D.; Nanni C.; Rizzello A.; Franchi R.; Fanti S., Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 35, pp. 1431 - 1438 [articolo]
Farace P.; Galiè M.; Nanni C.; Spinelli A.; Fanti S., Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4)., «INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS», 2008, 72, pp. 303 - 304 [replica/breve intervento]
Pantaleo M.A.; Nannini M.; Maleddu A.; Fanti S.; Ambrosini V.; Nanni C.; Boschi S.; Biasco G., Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
Review, «CANCER TREATMENT REVIEWS», 2008, 34, pp. 103 - 121 [articolo]
